Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Advicenne SA (ADVIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8205
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advicenne SA (Advicenne) is a developer of pediatric medicines. The company offers product portfolio such as ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It provides its products for the treatment of neurological diseases and renal disorders in children. Advicenne also offers products for the treatment epilepsy, anesthesia and dystonia. The company offers clinical research services by using statistical tools, approaches of meta-analysis and data modeling and simulation, among others. It works in partnership with other pharmaceutical companies. The company operates through its offices in Nimes, Montbonnot and Paris, France. Advicenne is headquartered in Nimes, France.

Advicenne SA (ADVIC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advicenne SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Licensing Agreements 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Equity Offering 13
Advicenne Pharma Raises USD32 Million in IPO of Shares 13
Asset Transactions 14
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 14
Advicenne SA – Key Competitors 15
Advicenne SA – Key Employees 16
Advicenne SA – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 20, 2018: Advicenne reports first-half 2018 results and confirms outlook for 2018 18
Apr 10, 2018: Advicenne 2017 Financial Results and Operational Perspectives for 2018 19
Corporate Communications 21
Sep 25, 2018: Advicenne Prepares its Expansion with Highly Experienced Industry Professionals 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Advicenne SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Deals By Therapy Area, 2012 to YTD 2018 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Advicenne Pharma Raises USD32 Million in IPO of Shares 13
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 14
Advicenne SA, Key Competitors 15
Advicenne SA, Key Employees 16
Advicenne SA, Other Locations 17

List of Figures
Advicenne SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advicenne SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Advicenne SA (ADVIC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adpo Group NV:企業の戦略的SWOT分析
    Adpo Group NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • UCB SA (UCB)-製薬・医療分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • TransUnion LLC:企業のM&A・事業提携・投資動向
    TransUnion LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransUnion LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Singulex Inc:企業の製品パイプライン分析2018
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • China Shipbuilding Industry Corp:企業の戦略・SWOT・財務情報
    China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CEZ, AS (CEZ)-エネルギー分野:企業M&A・提携分析
    Summary CEZ, a.s. (CEZ) is an integrated energy conglomerate that extracts and sells coal; generates and distributes electricity and heat; and trades in electricity, natural gas, and other commodities. It generates electricity from nuclear, coal, gas, hydro, solar, wind, and biogas sources. The comp …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • St. Joseph Health:企業の戦略的SWOT分析
    St. Joseph Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Stemgent Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stemgent Inc (Stemgent), a part of the ReproCELL Group is a biotechnology company that focuses on the development of innovative technology and application solutions for the advancement of stem cell research. The company’s product portfolio comprises antibodies, cell lines, cytokines / protei …
  • Midea Group Co Ltd:戦略・SWOT・企業財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Panasonic Corporation (6752):電力:M&Aディール及び事業提携情報
    Summary Panasonic Corporation (Panasonic) develops, Produces, sells and services a range of electric and electronic products in the areas of consumer electronics, housing, B2B and automotive sectors. Its product portfolio include room air-conditioners, TVs, refrigerators, washing machines, personal- …
  • Canadian Energy Services & Technology Corp. (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a persona …
  • Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterili …
  • Buckeye Partners LP (BPL):企業の財務・戦略的SWOT分析
    Buckeye Partners LP (BPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hindalco Industries Ltd:企業の戦略・SWOT・財務情報
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆